ArticleOncoimmunology2025

TIGIT blockade in the context of BCMA-CART cell therapy does not augment efficacy in a multiple myeloma mouse model.

Aina Oliver-Caldes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.